Tempest Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TPST and other ETFs, options, and stocks.

About TPST

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. 

CEO
Stephen R. Brady
CEOStephen R. Brady
Employees
25
Employees25
Headquarters
Brisbane, California
HeadquartersBrisbane, California
Founded
2011
Founded2011
Employees
25
Employees25

TPST Key Statistics

Market cap
27.85M
Market cap27.85M
Price-Earnings ratio
-0.41
Price-Earnings ratio-0.41
Dividend yield
—
Dividend yield—
Average volume
78.87K
Average volume78.87K
High today
$8.23
High today$8.23
Low today
$7.65
Low today$7.65
Open price
$7.99
Open price$7.99
Volume
37.74K
Volume37.74K
52 Week high
$49.27
52 Week high$49.27
52 Week low
$5.35
52 Week low$5.35
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.